LivDerm Articles

Explore Articles

Selector filter
Sort Post

A Recap of the SBS 2023 Cutaneous Oncology Symposium

South Beach Symposium (SBS) co-chair, David J. Goldberg, MD, JD, led the Cutaneous Oncology Symposium at this year's SBS.

Systemic Review Reveals the Top Values and Preferences of Patients and Caregivers When Treating Atopic Dermatitis

Researchers analyze the values and preferences of patients and their caregivers when being treated for atopic dermatitis.

Highlights from the Boxed Warning Toolkit Session at SBS

The Boxed Warning Toolkit, a brand-new session at the 2023 South Beach Symposium (SBS) was led by Christopher G. Bunick,…

SBS Recap: Anti-Aging and Integrative Medicine Track

The 2023 SBS featured an in-depth session covering Anti-Aging and Integrative Medicine, including the role of nutrients in skin health.

SBS 2023 Hot Topic: Applications of Genomics and How It Impacts Patient Care

The 2023 South Beach Symposium (SBS) included a brand-new hot topic, Applications of Genomics and How It Impacts Patient Care.

Dystrophic Epidermolysis Bullosa: Topical Gene Therapy Shows Promising Results

Recent phase three clinical trial shows topical gene therapy (B-VEC) help over half of patients see complete wound closure after…

How Precision Medicine Can Benefit Patients

Dr. Christopher Bunick discusses precision medicine, examining the role of genomics and personalized care for patients at SBS 2023.

A Recap of the 2023 South Beach Symposium

The 2023 South Beach Symposium (SBS) ended on Sunday, Feb. 12, after four incredible days of learning, discovery and networking.

A Recap of the 2023 Masters of Pediatric Dermatology Symposium

The 31st Annual Masters of Pediatric Dermatology (MOPD) Symposium came to an end on Friday, Feb. 10. Here's what you…

Nightly News: SBS 2023 Day Four

Today was the final day of SBS 2023! We are sad to say goodbye but are thrilled at having spent…

Nightly News: SBS 2023 Day Three

Day Three of the South Beach Symposium (SBS) featured a jam-packed agenda, including two dedicated specialty sessions.

Nightly News: SBS 2023 Day Two

Here is a recap of Day Two of the exciting South Beach Symposium (SBS) live from the Loews Resort in…

Nightly News: SBS 2023 Day One

The South Beach Symposium (SBS) has officially kicked off. Here are the highlights from Day One of the conference.

Dr. Karan Lal on Treating Patients with Epidermolysis Bullosa

Dr. Karan Lal recently discussed his experience treating Epidermolysis Bullosa (EB), a rare genetic skin disorder.

The American Academy of Dermatology Publishes Updated Guidelines for the Care and Management of Atopic Dermatitis

The American Academy of Dermatology has published updated guidelines for the care and management of atopic dermatitis.

Arcutis Biotherapeutics Submits Supplemental New Drug Application for Roflumilast Cream for the Treatment of Plaque Psoriasis in Children Down to 2 Years of Age

Arcutis Biotherapeutics has submitted a Supplemental New Drug Application to the FDA for the expanded indication of Zoryve cream for…

Skincare Sessions at SBS: Insight from Dr. Patricia Farris

Patricia K. Farris, MD recently shared some insight into the topics she will be covering at South Beach Symposium 2023.

Immunomic Therapeutics Receives FDA Fast-Track Designation 

The fast-track designation is for the clinical study of the plasmid DNA vaccine ITI-3000 in patients with Merkel cell carcinoma.

FDA Clears Accure Laser System for Acne 

Accure Acne, Inc. announced the FDA had cleared their Accure Laser™ System for treating mild-to-severe inflammatory acne vulgaris.

Study Shows Apremilast May Have Cardiometabolic Benefits for Patients with Psoriasis

Results from a nonrandomized clinical trial suggest that apremilast (Otezla), may have cardiometabolic health benefits for patients with psoriasis.


Sign up to receive updates on educational opportunities, complimentary content, exclusive discounts, and more.